Quantcast
Last updated on April 16, 2014 at 13:17 EDT

Latest King Pharmaceuticals Stories

2014-01-13 12:26:59

Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel for Stine Seed Company, Added to KemPharm's Board CORALVILLE, Iowa, Jan. 13, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today the appointment of Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel, Stine Seed...

2013-12-16 08:26:11

NEW YORK and SAYREVILLE, N.J., Dec. 16, 2013 /PRNewswire/ -- Avista Capital Partners ("Avista"), a leading private equity firm, and Vertical / Trigen Holdings ("Vertical / Trigen" or "the Company"), which owns Vertical Pharmaceuticals and Trigen Laboratories, today announced that Avista has acquired a controlling equity interest in Vertical / Trigen. Avista is partnering with co-founders Steven Squashic, Kevin Hudy, and David Purdy, who will remain in place and retain a significant...

2013-12-05 23:04:28

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) December 05, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals....

2013-10-09 23:23:02

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) October 09, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The...

2013-08-14 16:26:02

ZUG, Switzerland, Aug. 14, 2013 /PRNewswire/ -- Covis Pharma Holdings S.a.r.l. ("Covis Holdings") announced today the appointment of pharmaceutical industry veteran Dean J. Mitchell as Executive Chairman of the Board. Mr. Mitchell will be responsible for leadership of Covis Holdings and for the overall direction of the company. He replaces former Executive Chairman James T. Lenehan, who will continue to serve as a Director of the company. "Dean Mitchell's extensive experience in...

2013-07-01 23:18:54

Michael Valentino the former President and CEO of Xanodyne Pharmaceuticals, Inc. brings extensive track record and insight market results to UrgentRx. Denver, CO (PRWEB) July 01, 2013 UrgentRx, developer of fast acting over-the-counter flavored powder medications, today announced Michael Valentino will join the company's Board of Directors. Valentino brings more than 30 years of leadership experience at both major pharmaceutical companies and venture-backed start-ups. His most recent...

2013-05-29 12:26:48

BALTIMORE, May 29, 2013 /PRNewswire/ -- UPM Pharmaceuticals, a Baltimore, Maryland-based drug development and contract manufacturer, announced today that they will be acquiring the 500,000 square-foot commercial manufacturing facility that Pfizer Inc. (PFE) currently operates in Bristol, TN. The acquisition of the Pfizer facility will provide UPM with large scale commercial capabilities for manufacturing and packaging of solid oral dosage tablets and capsules, as well as...

2013-01-04 08:22:21

LOVELAND, Colo., Jan. 4, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that Carol Wrenn had joined Heska's Board of Directors. Ms. Wrenn is a founder and current President of Sky River Helicopters, LLC. From 2001 to 2009, she was President of the Animal Health Division and an Executive Vice President of Alpharma Inc. During her tenure at Alpharma, Ms. Wrenn is credited for...

2012-12-17 08:24:24

RALEIGH, N.C., Dec. 17, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today the hiring of George K. Ng as Senior Vice President & General Counsel. In this capacity, Mr. Ng will be responsible for overseeing BDSI's legal, compliance and intellectual property activities. Mr. Ng will report directly to Dr. Mark A. Sirgo, President and Chief Executive Officer. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO ) Mr. Ng has more than a...

2012-12-04 16:26:51

ALLEGAN, Mich., Dec. 4, 2012 /PRNewswire/ -- The Perrigo Company (Nasdaq: PRGO;TASE) today announced the appointment of Douglas Boothe as Executive Vice President and General Manager, Perrigo Pharmaceuticals, effective January 2013. Sharon Kochan, who previously held this position, has been managing the business in the interim since accepting the newly created role of Executive Vice President and General Manager, International in July 2012. (Logo:...